U.S. Markets closed

NovaBay Pharmaceuticals, Inc. (NBY)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.4644-0.0338 (-6.78%)
At close: 4:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 3.55
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 31.7900
52 Week Low 30.4500
50-Day Moving Average 30.5588
200-Day Moving Average 30.7208

Share Statistics

Avg Vol (3 month) 3898.56k
Avg Vol (10 day) 31.13M
Shares Outstanding 541.78M
Implied Shares Outstanding 6N/A
Float 835.67M
% Held by Insiders 120.64%
% Held by Institutions 12.65%
Shares Short (Oct 28, 2021) 41.59M
Short Ratio (Oct 28, 2021) 42.12
Short % of Float (Oct 28, 2021) 44.00%
Short % of Shares Outstanding (Oct 28, 2021) 43.54%
Shares Short (prior month Sep 29, 2021) 42.02M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:25
Last Split Date 3Dec 20, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Sep 29, 2021


Profit Margin -96.77%
Operating Margin (ttm)-96.84%

Management Effectiveness

Return on Assets (ttm)-31.66%
Return on Equity (ttm)-63.84%

Income Statement

Revenue (ttm)7.67M
Revenue Per Share (ttm)0.18
Quarterly Revenue Growth (yoy)-15.20%
Gross Profit (ttm)5.96M
Net Income Avi to Common (ttm)-7.42M
Diluted EPS (ttm)-0.3150
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.03M
Total Cash Per Share (mrq)0.2
Total Debt (mrq)196k
Total Debt/Equity (mrq)2.09
Current Ratio (mrq)4.00
Book Value Per Share (mrq)0.29

Cash Flow Statement

Operating Cash Flow (ttm)-6.32M
Levered Free Cash Flow (ttm)-3.46M